Each week on Saturday morning, the NeurologyLive® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.
Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition
Neurology News Network for the week ending May 6, 2023. [WATCH TIME: 4 minutes]
Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups
Neurology News Network for the week ending April 30, 2023. [WATCH TIME: 4 minutes]
DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy
Neurology News Network for the week ending April 22, 2023. [WATCH TIME: 4 minutes]
EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward
Neurology News Network for the week ending April 15, 2023. [WATCH TIME: 4 minutes]
Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA
Neurology News Network for the week ending April 8, 2023. [WATCH TIME: 4 minutes]
Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms
Neurology News Network for the week ending April 1, 2023. [WATCH TIME: 4 minutes]
Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea
Neurology News Network for the week ending March 25, 2023. [WATCH TIME: 3 minutes]
Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline
Neurology News Network for the week ending March 18, 2023. [WATCH TIME: 4 minutes]
Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching
Neurology News Network for the week ending March 11, 2023. [WATCH TIME: 3 minutes]
Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD
Neurology News Network for the week ending March 4, 2023. [WATCH TIME: 3 minutes]
Sodium Oxybate Alters Sleep Structure, FDA Approves Deutetrabenazine, Associations of Stroke Decreased With Age
Neurology News Network for the week ending February 26, 2022. [WATCH TIME: 3 minutes]
CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease
Neurology News Network for the week ending February 18, 2023. [WATCH TIME: 4 minutes]
PHOENIX Study Meets Enrollment, Atogepant and Ubrogepant Safe, ABATE Trial Highlights Targeted Response of Alzheimer Vaccine
Neurology News Network for the week ending February 11, 2023. [WATCH TIME: 3 minutes]
New Diagnostic Criteria Established for MOGAD, FDA Approves Proclaim XR SCS System, Clinical Hold on IKT-148009 Lifted
Neurology News Network for the week ending February 4, 2023. [WATCH TIME: 4 minutes]
Evoke SCS System Shows Positive 36-Month Results, FDA Lifts Hold on FORTIS, Complete Response Letter Issued for Donanemab
Neurology News Network for the week ending January 28, 2023. [WATCH TIME: 4 minutes]
COVID-19 Vaccine and Potential Stroke Concern, Associations Between AEDs and Incident Parkinson, FDA Accepts sBLA for DaxibolinumtoxinA
Neurology News Network for the week ending January 21, 2022. [WATCH TIME: 3 minutes]
24-Hour Levodopa Solution Improves ON Time, Eisai Submits sBLA for Traditional Approval of Lecanemab, Rare Case of Seronegative NMOSD Identified
Neurology News Network for the week ending January 14, 2022. [WATCH TIME: 4 minutes]
FDA Approves Essential Tremor Treatment, Alzheimer's Association Files Request to CMS, Duchenne Therapy ENTR-601-44 Placed on Hold
Neurology News Network for the week ending December 31, 2022. [WATCH TIME: 3 minutes]
WVE-N531's Impact on Exon Skipping, PROs Improved With Early DMT Initiation, Carbon Dioxide Improves Insomnia Sleep
Neurology News Network for the week ending December 24, 2022. [WATCH TIME: 4 minutes]
Genetic Links to PML Identified, MARINA Trial Findings Announced, Educational Videos Improve CPAP Adherence
Neurology News Network for the week ending December 17, 2022. [WATCH TIME: 4 minutes]
Communication Critical for Dravet Syndrome, DNL343 to Enter HEALEY ALS Trial, Combination of Seizures and Dementia Leads to Worse Outcomes
Neurology News Network for the week ending December 10, 2022. [WATCH TIME: 4 minutes]
Donanemab Outperforms Aducanumab in Amyloid Clearance, FDA Grants Priority Review to SRP-9001, Atogepant Improves PROs
Neurology News Network for the week ending December 3, 2022. [WATCH TIME: 3 minutes]
Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis
Neurology News Network for the week ending November 26, 2022. [WATCH TIME: 4 minutes]
Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis
Neurology News Network for the week ending November 19, 2022. [WATCH TIME: 3 minutes]
FDA Rejects BLA for NurOwn, Simvastatin Futile as DMT for Parkinson, Music Potentially Improves Insomnia Symptoms
Neurology News Network for the week ending November 12, 2022. [WATCH TIME: 4 minutes]
Poor Sleep Associated With Cannabis and Alcohol Use, Dietary Approaches in MS, Noninvasive Brain Stimulation Effective in Alzheimer
Neurology News Network for the week ending November 5, 2022. [WATCH TIME: 3 minutes]
Apitegromab Improves Quality of Life in SMA, ARB Therapy Leads to Lowered Epilepsy Risk, Donanemab Reduces Alzheimer-Related Plasma Biomarkers
Neurology News Network for the week ending October 28, 2022. [WATCH TIME: 4 minutes]
Positive Interim Report on Fosgonimeton, Lower ASPECTS Scores Impact Efficacy of EVT, FDA Extends Review of Tofersen
Neurology News Network for the week ending October 22, 2022. [WATCH TIME: 4 minutes]
Phase 3 LIGHTHOUSE Study Initiated, Trend Toward ASMs With Lower Teratogenic Risk, Rituximab Effects on NMOSD, MOGAD
Neurology News Network for the week ending October 15, 2022. [WATCH TIME: 3 minutes]
Ublituximab Outperforms Teriflunomide on ARRs, CNM-Au8 Fails HEALEY ALS Trial, Benefits of Aerobic Exercise in Multiple Sclerosis
Neurology News Network for the week ending October 8, 2022. [WATCH TIME: 3 minutes]